The preeclampsia diagnostics market is projected to reach USD 2.64 billion in 2025, driven by the rising prevalence of preeclampsia and pregnancy-related complications. With growing demand for early detection, biomarker-based screening, and point-of-care diagnostic tests, the market is expected to expand to USD 5.83 billion by 2033 at a CAGR of 10.40%. This episode explores innovations in maternal health diagnostics, predictive testing, and advancements in prenatal care aimed at improving outcomes for mothers and babies.